Published in Melanoma Res on February 01, 1994
Use of human tissue to assess the oncogenic activity of melanoma-associated mutations. Nat Genet (2005) 1.90
MAGE-A tumor antigens target p53 transactivation function through histone deacetylase recruitment and confer resistance to chemotherapeutic agents. Proc Natl Acad Sci U S A (2006) 1.82
Frequent p16-independent inactivation of p14ARF in human melanoma. J Natl Cancer Inst (2008) 1.78
Dual inactivation of RB and p53 pathways in RAS-induced melanomas. Mol Cell Biol (2001) 1.73
NF-kappaB activation in melanoma. Pigment Cell Res (2006) 1.55
Melanoma genetics and the development of rational therapeutics. J Clin Invest (2005) 1.50
Survivin repression by p53, Rb and E2F2 in normal human melanocytes. Carcinogenesis (2007) 1.29
p53 prevents progression of nevi to melanoma predominantly through cell cycle regulation. Pigment Cell Melanoma Res (2010) 1.21
High-level expression of wild-type p53 in melanoma cells is frequently associated with inactivity in p53 reporter gene assays. PLoS One (2011) 1.11
p53 mutations in human cutaneous melanoma correlate with sun exposure but are not always involved in melanomagenesis. Br J Cancer (1999) 1.08
Beyond BRAF(V600): clinical mutation panel testing by next-generation sequencing in advanced melanoma. J Invest Dermatol (2014) 1.07
Somatic p16(INK4a) loss accelerates melanomagenesis. Oncogene (2010) 0.99
Genetics and genomics of melanoma. Expert Rev Dermatol (2009) 0.98
Role of epidermal growth factor receptor signaling in RAS-driven melanoma. Mol Cell Biol (2005) 0.90
Dominant effects of Δ40p53 on p53 function and melanoma cell fate. J Invest Dermatol (2013) 0.87
p53 Protein-mediated regulation of phosphoglycerate dehydrogenase (PHGDH) is crucial for the apoptotic response upon serine starvation. J Biol Chem (2014) 0.86
p63 is an alternative p53 repressor in melanoma that confers chemoresistance and a poor prognosis. J Exp Med (2013) 0.85
Reduced Apaf-1 expression in human cutaneous melanomas. Br J Cancer (2004) 0.85
Resveratrol induces apoptosis by directly targeting Ras-GTPase-activating protein SH3 domain-binding protein 1. Oncogene (2014) 0.85
PTEN/MMAC1 expression in melanoma resection specimens. Br J Cancer (2002) 0.78
Mechanisms contributing to differential regulation of PAX3 downstream target genes in normal human epidermal melanocytes versus melanoma cells. PLoS One (2015) 0.78
Differential S-phase progression after irradiation of p53 functional versus non-functional tumour cells. Radiol Oncol (2014) 0.77
p53 regulation by TRP2 is not pervasive in melanoma. PLoS One (2014) 0.75
Panel sequencing melanomas. J Invest Dermatol (2015) 0.75
Melanoma: Molecular Pathogenesis and Therapeutic Management. Mol Cell Pharmacol (2015) 0.75
Renal-cell carcinoma. N Engl J Med (1996) 11.46
The ultrastructure of the cat myocardium. I. Ventricular papillary muscle. J Cell Biol (1969) 4.92
Melanocortin-1 receptor polymorphisms and risk of melanoma: is the association explained solely by pigmentation phenotype? Am J Hum Genet (2000) 4.74
The ultrastructure of the nexus. A correlated thin-section and freeze-cleave study. J Cell Biol (1970) 4.48
Membrane ultrastructure at mammalian intercellular junctions. Prog Biophys Mol Biol (1973) 4.30
The oxidation of malate by isolated plant mitochondria. Eur J Biochem (1972) 3.28
Natural history of early primary biliary cirrhosis. Lancet (1996) 3.24
Ethnicity and attitudes towards life sustaining technology. Soc Sci Med (1999) 2.93
A novel AKT3 mutation in melanoma tumours and cell lines. Br J Cancer (2008) 2.63
Contact-inhibited revertant cell lines isolated from SV 40-transformed cells. IV. Microfilament distribution and cell shape in untransformed, transformed, and revertant Balb-c 3T3 cells. J Cell Biol (1973) 2.40
CD34 staining pattern distinguishes basal cell carcinoma from trichoepithelioma. Arch Dermatol (1994) 2.33
Pathways for the oxidation of malate and reduced pyridine nucleotide by wheat mitochondria. Eur J Biochem (1973) 2.22
A major quantitative-trait locus for mole density is linked to the familial melanoma gene CDKN2A: a maximum-likelihood combined linkage and association analysis in twins and their sibs. Am J Hum Genet (1999) 2.15
Activation of the MAPK pathway is a common event in uveal melanomas although it rarely occurs through mutation of BRAF or RAS. Br J Cancer (2005) 2.13
Utility of step sections: demonstration of additional pathological findings in biopsy samples initially diagnosed as actinic keratosis. Arch Dermatol (2000) 2.12
The ultrastructure of the cat myocardium. II. Atrial muscle. J Cell Biol (1969) 2.09
A devonian spinneret: early evidence of spiders and silk use. Science (1989) 2.09
The SCF/KIT pathway plays a critical role in the control of normal human melanocyte homeostasis. J Invest Dermatol (1998) 2.08
Cytoplasmic accumulation of cdc25B phosphatase in mitosis triggers centrosomal microtubule nucleation in HeLa cells. J Cell Sci (1996) 1.99
Contact-inhibited revertant cell lines isolated from SV40-transformed cells. II. Ultrastructural study. J Cell Biol (1971) 1.96
A Taq I polymorphism for the human transforming growth factor alpha gene (TGFA). Nucleic Acids Res (1987) 1.88
Prognostic factors affecting long-term outcome after stem cell transplantation in Hodgkin's lymphoma autografted after a first relapse. Ann Oncol (2005) 1.88
Allelic and locus heterogeneity in inherited venous malformations. Hum Mol Genet (1999) 1.78
Genome scan of schizophrenia. Am J Psychiatry (1998) 1.74
Ras oncogene point mutation: an infrequent event in bronchioloalveolar cancer. J Thorac Cardiovasc Surg (1992) 1.72
Mice lacking the vascular endothelial growth factor-B gene (Vegfb) have smaller hearts, dysfunctional coronary vasculature, and impaired recovery from cardiac ischemia. Circ Res (2000) 1.72
A specific role for Ca2+ in the oxidation of exogenous NADH by Jerusalem-artichoke (Helianthus tuberosus) mitochondria. Biochem J (1981) 1.71
Immunohistochemical demonstration of factor XIIIa expression in neurofibromas. A practical means of differentiating these tumors from neurotized melanocytic nevi and schwannomas. Arch Dermatol (1990) 1.70
Neutral endopeptidase 24.11 loss in metastatic human prostate cancer contributes to androgen-independent progression. Nat Med (1998) 1.69
Phase III trial of interferon alfa-2a with or without 13-cis-retinoic acid for patients with advanced renal cell carcinoma. J Clin Oncol (2000) 1.67
MC1R genotype modifies risk of melanoma in families segregating CDKN2A mutations. Am J Hum Genet (2001) 1.67
Cisplatin, methotrexate, and vinblastine (CMV): an effective chemotherapy regimen for metastatic transitional cell carcinoma of the urinary tract. A Northern California Oncology Group study. J Clin Oncol (1985) 1.65
Melanoma of the gallbladder: a review of cases seen at Duke University Medical Center. Cancer (1999) 1.54
Leptin and the risk of Barrett's oesophagus. Gut (2008) 1.54
Renal allotransplantation in humans. I. Systemic immunosuppressive therapy. Arch Surg (1970) 1.52
Inducible nitric oxide synthase and nitrotyrosine in human metastatic melanoma tumors correlate with poor survival. Clin Cancer Res (2000) 1.52
Loss of expression of the p16/cyclin-dependent kinase inhibitor 2 tumor suppressor gene in melanocytic lesions correlates with invasive stage of tumor progression. Cancer Res (1995) 1.50
Thermodynamic and kinetic properties of an iron-porphyrin system. J Am Chem Soc (1971) 1.47
The CDKN2A (p16) gene and human cancer. Mol Med (1997) 1.46
Structural changes for speech improvement in complete upper denture fabrication. J Prosthet Dent (1979) 1.45
Phase II trial of imatinib mesylate in patients with metastatic melanoma. Br J Cancer (2008) 1.43
Gene expression of lung squamous cell carcinoma reflects mode of lymph node involvement. Eur Respir J (2007) 1.43
Renal cell carcinoma. Curr Probl Cancer (1997) 1.43
The influence of osmolarity on the reduction of exogenous cytochrome c and permeability of the inner membrane of Jerusalem artichoke mitochondria. Biochem J (1974) 1.41
Carcinogenesis in porokeratosis. Evidence for a role relating to chronic growth activation of keratinocytes. Am J Dermatopathol (1991) 1.40
Relevance of ultraviolet-induced N-ras oncogene point mutations in development of primary human cutaneous melanoma. Am J Pathol (1996) 1.36
Isolation of a cyanide-resistant duroquinol oxidase from Arum maculatum mitochondria. FEBS Lett (1978) 1.35
Solubilization of the alternative oxidase of cuckoo-pint (Arum maculatum) mitochondria. Stimulation by high concentrations of ions and effects of specific inhibitors. Biochem J (1985) 1.34
Membrane alterations during cornification of mammalian squamous epithelia: a freeze-fracture, tracer, and thin-section study. Anat Rec (1977) 1.34
Low frequency of p16/CDKN2A methylation in sporadic melanoma: comparative approaches for methylation analysis of primary tumors. Cancer Res (1997) 1.33
Histologic spectrum of neurothekeoma and the value of immunoperoxidase staining for S-100 protein in distinguishing it from melanoma. Am J Dermatopathol (1994) 1.32
Interleukin-10 production by human carcinoma cell lines and its relationship to interleukin-6 expression. Int J Cancer (1993) 1.31
Ethnicity and advance care directives. J Law Med Ethics (1996) 1.31
The contribution of the DFNB1 locus to neurosensory deafness in a Caucasian population. Am J Hum Genet (1995) 1.30
Analysis of ras oncogenes in malignant melanoma and precursor lesions: correlation of point mutations with differentiation phenotype. Oncogene (1989) 1.30
Inhibition of human peripheral blood mononuclear cell proliferation by Streptococcus pyogenes cell extract is associated with arginine deiminase activity. Infect Immun (1998) 1.27
Effects of forskolin on electrical behaviour of myenteric neurones in guinea-pig small intestine. J Physiol (1986) 1.26
Compilation of somatic mutations of the CDKN2 gene in human cancers: non-random distribution of base substitutions. Genes Chromosomes Cancer (1996) 1.25
Further observations on the occurrence of nexuses in benign and malignant human cervical epithelium. J Cell Biol (1971) 1.23
Early lesions of Kaposi's sarcoma in homosexual men. An ultrastructural comparison with other vascular proliferations in skin. Am J Pathol (1983) 1.23
Elevation of adenosine 3',5'-phosphate mimics slow synaptic excitation in myenteric neurones of the guinea-pig. J Physiol (1986) 1.23
Androgen receptor CAG repeat lengths in prostate cancer: correlation with age of onset. J Clin Endocrinol Metab (1996) 1.22
The influence of pH on the inhibition of oxidative phosphorylation and electron transport by triethyltin. Biochim Biophys Acta (1971) 1.22
Human cutaneous mast cells express basic fibroblast growth factor. Lab Invest (1995) 1.21
Activation of p300 histone acetyltransferase activity and acetylation of the androgen receptor by bombesin in prostate cancer cells. Oncogene (2006) 1.21
Experimental photoimmunotherapy of hepatic metastases of colorectal cancer with a 17.1A chlorin(e6) immunoconjugate. Cancer Res (2000) 1.20
Lignin peroxidase from Phanerochaete chrysosporium. Molecular and kinetic characterization of isozymes. Eur J Biochem (1990) 1.20
Down-regulated melanoma differentiation associated gene (mda-7) expression in human melanomas. Int J Cancer (2001) 1.19
The stimulation of exogenous NADH oxidation in Jerusalem artichoke mitochondria by screening of charges on the membranes. FEBS Lett (1979) 1.19
Expression of transforming growth factor-beta 2 in malignant melanoma correlates with the depth of tumor invasion. Implications for tumor progression. Am J Pathol (1994) 1.19
Antimitochondrial antibody negative primary biliary cirrhosis: a distinct syndrome of autoimmune cholangitis. Gut (1994) 1.18
Ultrastructure of intercellular junctions in adult and developing cardiac muscle. Am J Cardiol (1970) 1.18
A thin-section and freeze-fracture study of microfilament-membrane attachments in choroid plexus and intestinal microvilli. J Cell Biol (1978) 1.18
Mutations of the CDKN2/p16INK4 gene in Australian melanoma kindreds. Hum Mol Genet (1995) 1.18
Dermatologic findings and manifestations of acquired immunodeficiency syndrome (AIDS). J Am Acad Dermatol (1987) 1.17
Molecular cloning of the human kidney differentiation antigen gp160: human aminopeptidase A. Proc Natl Acad Sci U S A (1993) 1.16
Modulation of gastrointestinal function by MuDelta, a mixed µ opioid receptor agonist/ µ opioid receptor antagonist. Br J Pharmacol (2012) 1.16
Induction of growth factor RNA expression in human malignant melanoma: markers of transformation. Cancer Res (1991) 1.15
Neutral endopeptidase inhibits prostate cancer cell migration by blocking focal adhesion kinase signaling. J Clin Invest (2000) 1.15
Expression and localization of aminopeptidase A, aminopeptidase N, and dipeptidyl peptidase IV in benign and malignant human prostate tissue. Prostate (1997) 1.14
Regulation of malate oxidation in plant mitochondria. Response to rotenone and exogenous NAD+. Biochem J (1982) 1.13
Security procedures in a psychiatric emergency service. J Natl Med Assoc (1981) 1.12
Neuroimmune communication in the submucous plexus of guinea pig colon after infection with Trichinella spiralis. Gastroenterology (1994) 1.12
Immunocytochemical identification of Rochalimaea henselae in bacillary (epithelioid) angiomatosis, parenchymal bacillary peliosis, and persistent fever with bacteremia. Am J Surg Pathol (1992) 1.12
Use of horseshoe kidney in renal transplantation: technical aspects. Urology (1975) 1.11
Loss of the p16INK4a and p15INK4b genes, as well as neighboring 9p21 markers, in sporadic melanoma. Cancer Res (1996) 1.10
Mutations and defective expression of the WAF1 p21 tumour-suppressor gene in malignant melanomas. Melanoma Res (1995) 1.10
Carcinoma of the cervix: deficiency of nexus intercellular junctions. Science (1969) 1.10
High-dose therapy in diffuse large cell lymphoma: results and prognostic factors in 452 patients from the GEL-TAMO Spanish Cooperative Group. Ann Oncol (2003) 1.08
Ultrastructural comparison of the interface between epithelium and stroma in basal cell carcinoma and control human skin. Lab Invest (1976) 1.08
Neuropeptide-stimulated cell migration in prostate cancer cells is mediated by RhoA kinase signaling and inhibited by neutral endopeptidase. Oncogene (2006) 1.08
Purification and properties of succinyl-CoA synthetase from Jerusalem artichoke mitochondria. Biochim Biophys Acta (1966) 1.08
CDKN2A/p16 is inactivated in most melanoma cell lines. Cancer Res (1997) 1.07
Elevated expression of protein tyrosine kinase c-Yes, but not c-Src, in human malignant melanoma. Oncogene (1993) 1.07
Mutational analysis of the human p53 gene in malignant melanoma. Pigment Cell Res (1991) 1.07